Use of cffDNA to avoid administration of anti-D to pregnant women when the fetus is RhD-negative: implementation in the NHS.
about
Has Noninvasive Prenatal Testing (NIPT) Come of Age?Genome-Wide Sequencing for Prenatal Detection of Fetal Single-Gene Disorders.Cost-effectiveness of first trimester non-invasive fetal RHD screening for targeted antenatal anti-D prophylaxis in RhD-negative pregnant women: a model-based analysis.RHD alleles among pregnant women with serologic discrepant weak D phenotypes from a multiethnic population and risk of alloimmunization.Vox Sanguinis International Forum on application of fetal blood grouping: summary.Guideline for blood grouping and red cell antibody testing in pregnancy.
P2860
Use of cffDNA to avoid administration of anti-D to pregnant women when the fetus is RhD-negative: implementation in the NHS.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Use of cffDNA to avoid adminis ...... ve: implementation in the NHS.
@en
Use of cffDNA to avoid adminis ...... ve: implementation in the NHS.
@nl
type
label
Use of cffDNA to avoid adminis ...... ve: implementation in the NHS.
@en
Use of cffDNA to avoid adminis ...... ve: implementation in the NHS.
@nl
prefLabel
Use of cffDNA to avoid adminis ...... ve: implementation in the NHS.
@en
Use of cffDNA to avoid adminis ...... ve: implementation in the NHS.
@nl
P2093
P2860
P356
P1476
Use of cffDNA to avoid adminis ...... ve: implementation in the NHS.
@en
P2093
P2860
P304
P356
10.1111/1471-0528.13055
P577
2014-08-21T00:00:00Z